Systemic Bottlenecks & Misalignments
curecancer.ai · 3,553 words · saved by 1 readers
How AI Can, And Can't, Cure Cancer
Systemic Bottlenecks & Misalignments Notice: This content is under embargo until 16 March 2026. Please do not share. --> Password Required This site is currently in preview. Enter the password to continue. Incorrect password. Please try again. Continue Systemic Bottlenecks & Misalignments Even with strong science and advancing AI, breakthroughs for cancer stall inside systems built on misaligned incentives, regulatory inertia, and narrow optimization. This section explores how structural constraints limit progress: from reimbursement models and risk‑averse regulation to market failures that di
saved by
related reading
- AI vs Cancercurecancer.ai
- Why is progress in biology so slow?sam-rodriques.com
- Dario Amodei — We Must Pace the Frontierdarioamodei.com
- Rebuild Biotech for the AI Era | Benchlingbenchling.com
- Medical AI isn't the bottleneck to medical progress | Mechanize, Inc.mechanize.work
- Intelligence is not the main bottleneck - by Ruxandra Teslowritingruxandrabio.com
- Current AIs seem pretty misaligned to me — LessWronglesswrong.com
- Drug Discovery Has No Magic Wandsa16z.news
- AI Versus Eroom's Lawsubstack.com
- Off Target | CNAScnas.org
- What failure looks like — AI Alignment Forumalignmentforum.org
- Designing AI for Disruptive Scienceasimov.press